Research Article

Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis

Table 4

Subgroup analysis of the LHIPEC + NIPS intervention in the conversion group patients.

LHIPEC + NIPS in the conversion groupPreinterventionPostintervention

PCI score17.44 ± 8.98.83 ± 6.1
AscitesAmount (ml)1974.12 ± 829.6442.65 ± 22.6
Positive cytology (%)19 (55.4%)3 (8.82%)
PS (ECOG)0.882 ± 0.120.441 ± 0.01
VAS1.471 ± 0.471.882 ± 0.380.092

LHIPEC: laparoscopic hyperthermic intraperitoneal chemotherapy; NIPS: neoadjuvant intraperitoneal and systemic chemotherapy; PCI: peritoneal cancer index; PS (ECOG): patient performance (Eastern Cooperative Oncology Group); VAS: visual analog scale.